Mindpeak selected as one of the top 10 German Startups

April 16, 2020
Mindpeak is already one of the best startups in Germany: The Hamburg-based company made it into the top 10 at the German Founders' Award 2020. Every year, the most innovative and best start-up ideas in Germany are selected in five categories at the renowned competition. The top 3 will be nominated the following week and the winner will be announced in September.

Mindpeak is already one of the best startups in Germany: The Hamburg-based company made it into the top 10 at the German Founders' Award 2020. Every year, the most innovative and best start-up ideas in Germany are selected in five categories at the renowned competition. The top 3 will be nominated the following week and the winner will be announced in September.

“I am very happy about this great nomination. The fact that we have come this far is not only an award for our innovative products for AI-assisted cancer diagnosis, but primarily for our competent and creative team. I would like to thank everyone for their committed work, especially in these challenging times, ”said founder and managing director Felix Faber in Hamburg.

Mindpeak was founded two years ago by Felix Faber and Dr. Tobias Lang and has developed AI software to increase the productivity of pathologists in clinical routine and to enable more precise cancer diagnoses. Mindpeak works with renowned research institutions such as the Charité Berlin and laboratories in Hamburg and Cambridge. The software is immediately ready for use in the laboratory without extensive pre-adjustment. The first product - breast cancer quantification software - is already on the market. Work is currently underway to expand the product portfolio to include more types of cancer.

The Mindpeak team is made up of the world's leading AI experts and alumni from Cambridge University, UC Berkeley, SCR Princeton and TU Munich. CEO Faber is an experienced entrepreneur with a successful exit and IPO. Co-founder Dr. Tobias Lang developed deep learning solutions for large e-commerce companies that are used by millions of people every day. Both founders studied computer science and artificial intelligence.

BreastIHC can currently only be used for research purposes.

Deutscher Gründerpreis

In the News

Related reading

In the News
8 min read

Mindpeak Expands to the United States with New Headquarters in Boston

We are proud to announce the official launch of Mindpeak Inc. in Boston, establishing our new US headquarters at the heart of the world’s leading pharma, biotech, and diagnostics ecosystem.

This milestone represents more than the opening of an office. It reflects our commitment to collaborating closely with innovators across the United States to:

  • Accelerate biomarker discovery and companion diagnostics
  • Advance the development of cancer therapies
  • Enable faster, more precise matching of treatments to patients

With a permanent presence in the US, we are making advanced AI-powered pathology part of everyday workflows—providing reproducible, high-quality insights that transform complex data into better patient outcomes.

At Mindpeak, we look forward to building strong partnerships and shaping the future of precision medicine together.

Read the full article here

In the News
8 min read

Mindpeak Featured in Ada Ventures’ Bio‑Infrastructure Spotlight

We’re excited to share that Mindpeak has been recognized by Ada Ventures as part of a select group of innovators building the next-generation infrastructure for global health.

In their recent spotlight, Ada Ventures highlights the urgency of rethinking healthcare systems to meet the demands of a longer-living, more complex global population. Their vision spans five critical pillars of bio‑infrastructure—from lab automation to talent development, with Mindpeak featured under "Patient Data Platforms" for our contributions to secure, inclusive, and actionable health data.

At Mindpeak, we’re proud to play a pivotal role in this transformation:

Advancing Precision Diagnostics

Our AI software brings cutting-edge biomarker translation directly into pathology workflows—supporting clinicians in identifying breast, lung, and other cancers with speed and precision.

Making Patient Data Clinically Useful

Unlike conventional data platforms, we focus on real-time, tissue-based insights that are immediately actionable in the clinic. This enables faster decision-making and more equitable access to personalized care.

Scaling Globally

With deployments across 20+ countries and partnerships with leading labs, we’re not just imagining the future, we’re delivering it, one slide at a time.

We’re honored to be included alongside visionary companies across the healthcare and life sciences ecosystem. Together, we’re helping build a world where AI, data, and infrastructure truly serve everyone.

🔗 Read Ada Ventures’ full bio‑infrastructure spotlight

In the News
8 min read

Mindpeak GmbH featured at AlbionVC HLTH 2025

We’re thrilled that Mindpeak GmbH has been featured in the AlbionVC HLTH Europe HealthTech Market Map 2025, which includes leading companies across digital care and digital pharma in Europe!

Explore the European HealthTech landscape in AlbionVC’s interactive map: https://lnkd.in/da6H84sJ

Ready to advance your diagnostics

Connect with our team to explore how precision pathology works in your setting